| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Genelux Corporation (GNLX) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 15 sells. GNLX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 534.8K | $1.56M | - | |
| Dir | 472.8K | $1.38M | -10,000 | |
| Other | 275.0K | $803.0K | - | |
| Other | 270.0K | $788.4K | - | |
| Other | 155.2K | $453.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Szalay Aladar78 | - | Sell | 64,857 | $2.65 | $171,678.28 | -5.0% | +3.3% | +61.9% | |
| Sep 11, 2024 | Tyree James L51 | - | Sell | 1,730 | $2.60 | $4,498.87 | -3.5% | +4.6% | +40.4% | |
| Sep 11, 2024 | Szalay Aladar78 | - | Sell | 75,143 | $2.62 | $196,608.84 | -3.5% | +4.6% | +40.4% | |
| Sep 3, 2024 | Szalay Aladar78 | 10% Owner | Sell | 42,818 | $2.09 | $89,613.79 | -5.5% | +36.5% | +59.1% | |
| Aug 30, 2024 | Szalay Aladar78 | 10% Owner | Sell | 265,552 | $2.09 | $554,410.54 | -8.8% | +24.0% | +53.5% | |
| Aug 27, 2024 | Szalay Aladar78 | 10% Owner | Sell | 91,630 | $2.19 | $200,277.85 | -4.1% | +22.5% | +74.2% | |
| Jun 24, 2024 | Jewett Caroline | Head Of Quality | Sell | 4,961 | $2.12 | $10,517.32 | -23.5% | -5.7% | +21.9% | |
| Jun 24, 2024 | Yu Yong78 | VP, Clinical Trial Operations | Sell | 6,849 | $2.12 | $14,519.88 | -38.7% | -5.7% | +21.9% | |
| Jun 24, 2024 | Ryder Sean52 | General Counsel | Sell | 5,496 | $2.12 | $11,651.52 | -22.1% | -5.7% | +21.9% | |
| May 29, 2024 | Yu Yong78 | VP, Clinical Trial Operations | Buy | 2,500 | $0.00 | - | New | -25.4% | -12.1% |